Tetracyclines and the treatment of corneal stromal ulceration: A review

Cornea

Volumn 19, Issue 3, 2000, Pages 274-277

  Ralph, Robert A ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

1 antitrypsin; Acid; Alkali; Chemical injury; Collagenase; Cornea; Corneal epithelium; Corneal stroma; Matrix metalloproteinase; Polymorphonuclear cell; Tetracycline; Ulceration

Indexed keywords

TETRACYCLINE DERIVATIVE;

COLLAGEN DEGRADATION; CORNEA ULCER; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EYE INJURY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

ANIMALS; BURNS, CHEMICAL; CORNEAL STROMA; CORNEAL ULCER; EYE BURNS; FIBROBLASTS; FREE RADICAL SCAVENGERS; HUMANS; METALLOENDOPEPTIDASES; NEUTROPHILS; TETRACYCLINES; WOUND HEALING;

EID: 0034029076     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200005000-00003     Document Type: Review

References (39)

1. Birk DE, Trelstad RL. Extracellular compartments in matrix morphogenesis: collagen fibril, bundle and lamellar formation by corneal fibroblasts. J Cell Biol 1984;99:2024-33.
2. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci 1990; 31:1779-88.
3. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70-6.
4. Johnson-Muller B, Gross J. Regulation of corneal collagenase production: epithelial-stromal cell interactions. Proc Natl Acad Sci U S A 1978;75:4417-21.
5. Johnson-Wint B, Bauer EA. Stimulation of collagenase synthesis by a 20,000 dalton epithelial cytokine. J Biol Chem 1985;260:2080-5.
6. Pfister RR, Haddox JL, Sommers CI, Lam KW. Identification and synthesis of chemotactic tripeptides from alkali-degraded whole cornea: a study of N-acetyl-proline-glycine-proline and N-methyl-prolineglycine-proline. Invest Ophthalmol Vis Sci 1995;36:1306-16.
7. Nagase H, Itoh Y, Binner S. Interaction of alpha-2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. Ann N Y Acad Sci 1994;732:294-302.
8. Berman MB, Barber JC, Talamo RT, Langley CE. Corneal ulceration and the serum antiproteases. I. Alpha-1-antitrypsin. Invest Ophthalmol 1973;12:759-70.
9. Slansky HH, Berman MB, Dohlman CH, et al. Cysteine and acetylcysteine in the prevention of corneal ulcerations. Ann Ophthalmol 1970;2:488-94.
10. Ditto V-J, Firth JD, Nip L, Golub LM. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann N Y Acad Sci 1994;732:140-51.
11. Yanoff M, Fine BS. Basic principles of pathology. In: Yanoff M, Fine BS, eds. Ocular pathology. 4th ed. London: Mosby-Wolfe, 1996:1-26.
12. Cameron JD. Corneal reaction to injury. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: fundamentals of cornea and external disease. St. Louis: Mosby, 1997:163-82.
13. Schultz GS. Modulation of corneal wound healing. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: fundamentals of cornea and external disease. St. Louis: Mosby, 1997:183-98.
14. Golub LM, Lee H-M, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983; 18:516-26.
15. Golub LM, Wolff M, Lee H-M, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985;20:12-23.
16. Perry HD, Golub LM. Systemic tetracyclines in the treatment of non-infected corneal ulcers: a case report and proposed new mechanism of action. Ann Ophthalmol 1985;17:742-4.
17. Seedor JA, Perry HD, Buxton DF, et al. Systemic tetracycline in the treatment of alkali induced corneal ulceration in the rabbit. Invest Ophthalmol Vis Sci 1985;26(suppl):319.
18. Szmyd L Jr, Spector SM, Perry HD, et al. Topical tetracycline in the treatment of alkali-induced corneal ulceration in the rabbit. Invest Ophthalmol Vis Sci 1986;27(suppl):208.
19. Perry HD, Kenyon KR, Lamberts DW, et al. Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial detects. Ophthalmology 1986;93:1320-2.
20. Seedor JA, Perry HD, McNamara TF, et al. Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits. Arch Ophthalmol 1987;105:268-71.
21. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-4.
22. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 1989;30:1569-75.
23. Levy JH, Katz HR. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit. Ann Ophthalmol 1990;22:179-83.
24. Pfister RR, Haddox JL, Dodson RW, Harkins LE. Alkali-burned collagen produces a locomotory and metabolic stimulant to neutrophils. Invest Ophthalmol Vis Sci 1987;28:295-304.
25. Pfister RR, Pfister DA. Alkali-injuries of the eye. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: fundamentals of cornea and external disease. St Louis: Mosby, 1997:1443-51.
26. Lauhio A, Konttinen YT, Salo T, et al. The in vivo effect of doxycycline treatment on matrix metalloproteinases in reactive arthritis. Ann N Y Acad Sci 1994;732:431-2.
27. Sorsa T, Ingman T, Suomalainen K, et al. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontal 1992;19:146-9.
28. Suomalainen K, Sorsa T, Ingman T, Lindy O, Golub LM. Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo. Oral Microbiol Immunol 1992;7: 121-3.
29. Suomalainen K, Halinen S, Ingman T, et al. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases. Drugs Exp Clin Res 1992;18:99-104.
30. Ingman T, Sorsa T, Suomalainen K, et al. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases: a review article. J Periodontol 1993;64: 82-8.
31. Nip LH, Uitto VJ, Golub LM. Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodontal Res 1993:28:379-85.
32. Ramamurthy NS, Vernillo AT, Greenwald RA, et al. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res 1993;8:1247-53.
33. Sorsa T, Konttinen YT, Lindy O, et al. Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase. Agents Actions Suppl 1993;39:225-9.
34. Sorsa T, Lindy O, Konttinen YT, et al. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother 1993;37:592-4.
35. Humbert P, Faivre B, Gibey R, Agache P. Use of anti-collagenase properties of doxycyline in treatment of alpha-1-antitrypsin deficiency panniculitis. Acta Derm Venereal 1991;71:189-94.
36. Thomas J, Crout R, Cook D. Antibiotic resistance evaluation with low dose doxycycline in adult periodontitis [Abstract], J Dent Res 1995; 74:1394.
37. Klein NC, Cunha BA. Tetracyclines. Med Clin North Am 1995;79: 789-801.
38. Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc 1994;69:169-80.
39. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997;133:1224-30.